Retrospective Multicenter Clinical Evaluation of Complications for Single or Multilevel VEO® Lateral Access and Interbody Fusion System and eXtreme Lateral Interbody Fusion (XLIF®) Subjects
Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Baxano Surgical, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Accepted
You may be eligible if
Adult 18 years of age or older;
Male or female VEO® subjects that had previously received the single or two level LLIF procedure using the VEO® or XLIF® systems as an adjunct to fusion at L2-S1 to treat degenerative disc disease (DDD) at the treated level;
Subject that was treated no less than 3 months prior to this evaluation with the LLIF procedure using the VEO® or XLIF® system by the participating surgeons.
You may not be if
Subject who did not receive LLIF procedure using the VEO® or XLIF® system for fusion of L2-S1;
Subjects with less than 3 months of follow-up data.
Clareo Health | Retrospective Multicenter Clinical Evaluation of Complications for Single or Multilevel VEO® Lateral Access and Interbody Fusion System and eXtreme Lateral Interbody Fusion (XLIF®) Subjects
